Biogen Idec Inc (BIIB)

BIIB (NASDAQ:Drugs)
$290.54
neg -0.94
-0.32%
Today's Range: 289.76 - 296.00 | BIIB Avg Daily Volume: 1,803,400
Last Update: 04/17/14 - 4:00 PM EDT
Volume: 1,283,744
YTD Performance: 3.92%
Open: $291.00
Previous Close: $291.48
52 Week Range: $194.66 - $358.89
Oustanding Shares: 236,393,930
Market Cap: 68,904,102,716
6-Month Chart
TheStreet Ratings Grade for BIIB
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 13 14 14 14
Moderate Buy 0 0 0 0
Hold 6 6 6 6
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.63 1.60 1.60 1.60
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 45.06
Price Earnings Comparisons:
BIIB Sector Avg. S&P 500
45.06 37.30 29.01
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-2.33% 42.37% 250.22%
GROWTH 12 Mo 3 Yr CAGR
Revenue 32.60 0.47 0.14
Net Income 34.90 1.07 0.27
EPS 35.70 0.97 0.25
Earnings for BIIB:
EBITDA 1.90B
Revenue 5.81B
Average Earnings Estimates
Qtr (03/14) Qtr (06/14) FY (12/14) FY (12/15)
Average Estimate $2.58 $2.68 $11.29 $14.56
Number of Analysts 4 4 4 4
High Estimate $2.79 $2.73 $11.73 $15.69
Low Estimate $2.48 $2.62 $11.13 $13.25
Prior Year $1.96 $2.30 $8.93 $11.29
Growth Rate (Year over Year) 31.38% 16.30% 26.40% 28.99%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Algos think faster and react faster than humans can.
Cautionary tales that the IPO window might be closing at last.

Fitz Bits: The Biotech Wreck Real Money Pro($)

These stocks are broken -- and you can't un-break them

Fitz Bits: The Biotech Wreck Real Money Pro($)

These stocks are broken -- and you can't un-break them
Bullish
Mar 06, 2014 | 7:55 AM EST
BIIB was upgraded to Outperform, BMO Capital said. $422 price target. Company has attractive near-term growth opportunities in its prod...
Bullish
Feb 20, 2014 | 8:14 AM EST
BIIB estimates were raised through 2015, Leerink Swann said. Estimates also raised, given higher expected Elocate sales. Outperform rat...
These sectors have shown some fight.
And valuation of individual stocks comes back into play.
I like living, breathing examples of growth stocks going right.

Three Plays on the Table Real Money Pro($)

I'm using the market's push lower to buy strong charts.

Columnist Conversations

There were nice reversal-type candles on the weekly charts of the major indices. The DOW and the S&P forme...
A number of stocks on my watch lists are attempting to form positive candles a key support levels. I noted th...
Lang:
While last week was a day to pull the plug and contemplate where the market was headed, I waited for some conf...
Shares of TSLA have formed multiple hammer candles at a key level of support defined by: the September head an...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.